UCL Institute of Ophthalmology


2017 uide to UCL Institute of Ophthalmology and Moorfields Eye Hospital presentations at ARVO

11 April 2017


We always have a big presence at the ARVO annual meeting, and this year is no exception, with over fifty of our researchers presenting their groundbreaking work.

ARVO is the largest and most respected eye and vision research organization in the world, presenting research projects at their annual meeting is highly competitive and to have this many projects presented is a real achievement.

This really is a huge credit to us, showcasing the extensive and pioneering research taking place in partnership between UCL & Moorfields.

If you will be attending ARVO and would like to find out more about the work we're doing; Anthony Khawaja has compiled the 2017 definitive guide to UCL Institute of Ophthalmology and Moorfields Eye Hospital presentations at ARVO to help you know where to find us.

May 6th

Start TimeEnd TimeSpeakersTitlePresentationLocation
11:0511:25Adnan TufailBig Data: Current status and future directionsApplications of Machine Learning and Deep LearningRoom 307
14:0014:30Ana QuartilhoDemystifying statistics and research for ophthalmic investigatorsFuss about p-value: How do I compare two treatments? Why is the p-value never enough?Room 309
15:1515:45Ana QuartilhoDemystifying statistics and research for ophthalmic investigatorsMissing data: Why does it matter? How to approach the challenges it presents?Room 309

May 7th

Start TimeEnd TimeSpeakersTitlePresentationLocation
08:3010:15Maria GemenetziAMD Imaging 1A0034: Optical coherence tomography angiography in treated neovascular age related macular degenerationExhibit/ Poster Hall
13:3015:15Karen EastlakeDeterminants of PR development and repairA0207: Comparison of zebrafish retinal proteins during experimental degeneration and regeneration using quantitative proteomicsExhibit/ Poster Hall
13:3015:15Bish PalAMD Imaging 2A0250: Quantitative Assessment and Comparison Of Choroidal Neovascular Membranes Of Different Etiologies Using Two Different Optical Coherence Tomography Angiography DevicesExhibit/ Poster Hall
13:3015:15Vijay TailorStructural/functional genomics and gene variantsB0147: The Oculome: a genetic test to diagnose a diverse range of ocular birth anomaliesExhibit/ Poster Hall
13:3015:15Tobias Weinrich WeinrichBiochemistry and molecular biology of the retinaB0177: Does S cone vulnerability reside in their mitochondria?Exhibit/ Poster Hall
13:3015:15Zaid ShalchiCataract Surgery Outcomes and EpidemiologyB0629: Characterizing posterior capsule rupture during cataract surgery in eyes with prior intravitreal injectionExhibit/ Poster Hall
13:4813:53Peng KhawAddressing global blindness and eye diseases through researchGlobal Experimental Medicine - the UNITE ConsortiumRoom 310
13:5313:58:0Richard LeeAddressing global blindness and eye diseases through researchGlobal Experimental Medicine - the UNITE ConsortiumRoom 310
15:1517:00Maria EleftheriadouAMD and anti-VEGF therapy 2A0053: Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naïve Patients with Neovascular Age-related Macular DegenerationExhibit/ Poster Hall
15:1517:00Valerie SawCataract Surgery - IOLsB0642: Outcomes of the Haigis-L formula for calculating intraocular lens power after myopic and hyperopic laser refractive surgery in a tertiary teaching hospitalExhibit/ Poster Hall

May 8th

Start TimeEnd TimeSpeakersTitlePresentationLocation
08:3010:15Tjebo HeerenOCT applicationsA0024: Progression of Ellipsoid Zone Loss correlates with Change of Scotoma Size in Macular Telangiectasia Type 2.Exhibit/ Poster Hall
08:3010:15Daren HanumunthaduOCT applicationsA0036: Comparison of spectral-domain and swept-source optical coherence tomography in the detection of neovascular age related macular degeneration disease activityExhibit/ Poster Hall
08:3010:15Anastasia TasiopoulouOCT applicationsA0053: Characteristic optical coherence tomography findings in a case series of patients with primary vitreoretinal lymphoma: A novel aid to early diagnosis.Exhibit/ Poster Hall
08:3010:15Tunde PetoRetinal DiseasesB0174: Retinal vascular calibres in older HIV-positive men compared to HIV-negative and younger HIV+ controlsExhibit/ Poster Hall
08:3010:15Eleni VrizidouRetinal vascular diseases I (excluding diabetes)B0386: 1 year-Real world clinical audit of aflibercept use in the management of macular edema secondary to central retinal vein occlusion at Moorfields Eye HospitalExhibit/ Poster Hall
10:0010:15Alessia FiorentinoGenotype-phenotype correlations, prevalence studies and novel gene defectsMutations in the X-linked gene PRPS1 cause retinal degeneration in femalesRoom 314
11:0012:45J Emanuel CarvalhoClinical applications of OCT angiographyA0117: Assessment Of Subclinical Microvascular Flow Characteristics In Aneurysmal Retinal Vasculitis Using Optical Coherence Tomography AngiographyExhibit/ Poster Hall
14:0514:25Gary RubinLV: Reading with low vision: What we know and need to knowFuture directions for low vision reading research: Building the evidence base - Presented by the 2017 Recipient of the Oberdorfer Award in Low Vision ResearchRoom 308
14:0514:10Karen BonsteinNovel models and trends for accelerating applied ophthalmic product discovery and developmentHow patient and public involvement is influencing the relevancy of modern healthcareRoom 310
14:1014:15Andrew SkiltonNovel models and trends for accelerating applied ophthalmic product discovery and developmentHow patient and public involvement is influencing the relevancy of modern healthcareRoom 310
15:4517:30Jonathan ClarkeClinical Trials and Drug Studies IA0163: Efficacy and safety of a new preservative-free fixed combination latanoprost-timolol (T2347) for open-angle glaucoma or ocular hypertensionExhibit/ Poster Hall
15:4517:30Cynthia Yu-Wai-ManGenetics of glaucomaA0246: Genome-wide RNA-Sequencing analysis reveals a distinct fibrosis gene signature in the conjunctiva after glaucoma surgeryExhibit/ Poster Hall
15:4517:30Sophia ZagoraUveitis: Diagnosis, Epidemiology, Quality of LifeA0253: Assessment of structure function correlation and response to treatment in uveitic cystoid macula edema using non-invasive Optical Coherence Tomography AngiographyExhibit/ Poster Hall
15:4517:30Chrysoula KoutsioukiUveitis: Diagnosis, Epidemiology, Quality of LifeA0267: Retinal Microvasculature changes in Birdshot Retinochoroiditis (BRC) detected by Optical Coherence Tomography AngiographyExhibit/ Poster Hall
15:4517:30Matthew PilgrimBruch's membrane and choroid in macular diseaseB0220: A mineralomic study of the retinal pigment epithelium-Bruch’s membrane complex in human eyes with age-related macular degenerationExhibit/ Poster Hall
16:3016:45Rupert StraussInherited retinal diseases and mactelProgression of Atrophic Lesions Determined by Fundus Autofluorescence: The Natural History of the Progression of Atrophy secondary to Stargardt Disease (ProgStar) StudyBallroom 3

May 9th

Start TimeEnd TimeSpeakersTitlePresentationLocation
08:3010:15Mahmood El-GasimDiabetic Eye DiseaseB0543: Changes in glycated hemoglobin levels following consultation with diabetes specialist nurse in retinal clinicsExhibit/ Poster Hall
09:4510:00Panayiota FountiClinical Trials and Drug Studies IIRisk factors for glaucoma progression in the United Kingdom Glaucoma Treatment Study (UKGTS)Ballroom 4
11:0012:45Adam DubisBlood flowA0028: Retinal morphology and vessel oxygen saturation in normal and diabetic patientsExhibit/ Poster Hall
11:0012:45Sobha SivaprasadAMD Clinical Research 2B0347: Content validity of the NEI VFQ-25 in patients with geographic atrophyExhibit/ Poster Hall
11:0012:45James TeeRetinitis pigmentosa (clinical)B0370: Assessment of Interocular Disease Progression in Retinitis Pigmentosa GTPase Regulator (RPGR)-associated Retinopathy with Quantitative Fundus Autofluorescence (FAF) Image AnalysisExhibit/ Poster Hall
11:0012:45Rola Ba-AbbadRetinitis pigmentosa (clinical)B0357: Dysplasia and degeneration in NR2E3 retinopathy: an imaging studyExhibit/ Poster Hall
11:0012:45Annegret Dahlmann-NoorPapilledema, IIH and Optic NerveB0580: Ultrasonography, OCT and OCT-angiography in the diagnostic workup of children with suspected papilledemaExhibit/ Poster Hall
13:4014:00Tessa DekkerVSS at ARVO - Functional Brain Imaging in Development and DisorderDevelopment of retinotopic representations in visual cortex during childhoodRoom 309
15:4517:30Moritz DanielTrabecular Meshwork and Ciliary BodyA0089: Dynamic changes of iridocorneal angle morphology during accommodation in healthy childrenExhibit/ Poster Hall
15:4517:30Almudena Sacristan ReviriegoCellular mechanisms of retinal diseases and ocular therapeuticsB0156: Functional assessment of AIPL1 variations identified in Leber Congenital Amaurosis patientsExhibit/ Poster Hall
15:4517:30Ferenc SalloMacular diseases (non-inherited)B0312: Distribution and progression patterns of retinal low-reflective intraretinal spaces in Type 2 Idiopathic Macular Telangiectasia.Exhibit/ Poster Hall
15:4517:30Laure Van BolMacular diseases (non-inherited)B0315: Characterisation of phenotypes of poppers maculopathy and their link with the visual prognosis and the resolution of OCT changesExhibit/ Poster Hall
15:4517:30Anthony KhawajaGlaucomaB0490: A protective association of selective serotonin reuptake inhibitors and a harmful association of calcium channel blockers for primary open-angle glaucoma identified in a healthcare database analysisExhibit/ Poster Hall

May 10th

Start TimeEnd TimeSpeakersTitlePresentationLocation
08:3010:15Izabela KlaskaAngiogenesis: Basic MechanismsB0036: Human opticin reduces pathological preretinal neovascularization in the mouse model of oxygen-induced retinopathy.Exhibit/ Poster Hall
11:0012:45Sahar AwwadDrug delivery IB0065: In vitro in vivo correlation of dexamethasone TIPS particlesExhibit/ Poster Hall
11:0012:45Panagiotis VasilopoulosMacular diseases (inherited)B0512: Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticumExhibit/ Poster Hall
11:0012:45Simona Degli EspostiVision in aging and diseaseB0648: Exploration of the phenomenon of regression to the mean in visual acuity measurements in patients with age-related macular degenerationExhibit/ Poster Hall
11:0011:15Neruban KumaranColor vision, low visionSevere Loss of Tritan Colour Discrimination in RPE65 Associated Leber Congenital AmaurosisRoom 316
13:2113:37David Garway-HeathMOI: Advanced interpretation of structural retinal optical coherence tomographyUnderstanding Visual Function Through ImagingBallroom 2
15:4517:30Roy SchwartzImaging technology and applicationsA0340: The distribution of macular pigment in different macular diseasesExhibit/ Poster Hall
15:4517:30Mali OkadaClinical electrophysiologyB0275: Electrophysiological Characterization of Macular Telangiectasia Type 2 (MacTel)Exhibit/ Poster Hall
15:4517:30Corrado GizziSurgery and Wound HealingB0362: Is bleb needling after failed trabeculectomy a procedure worth considering? 5 year outcome with a standardized technique.Exhibit/ Poster Hall
16:5017:10Peter CoffeyThe bench and the bedside: Who is the instructor? - MinisymposiumHuman Embryonic Stem Cell derived Retinal Pigment Epithelium transplantation in severe exudative Age-Related Macular Degeneration: so far so visual.Room 310
17:0017:15Gary RubinLow Vision Devices and RehabilitationFirst results from the EFFECT Trial, an RCT of eccentric viewing training for patients with AMDRoom 308

May 11th

Start TimeEnd TimeSpeakersTitlePresentationLocation
08:3010:15Sarah HoustonNeurodegenerative Diseases and Brain TraumaB0005: Microvascular Abnormalities and Inner Retinal Thickness in Multiple SclerosisExhibit/ Poster Hall
08:3010:15Weixin WangNon-neural cells of the retina: Glia and MicrogliaB0545: Comparative effects of Transforming growth factor-β1 and Heparin-binding epidermal growth factor on the production of anti-oxidants by human Müller glial cellsExhibit/ Poster Hall
08:3010:15Reena ChopraAdvancements in OCTB0597: Human Factor and Usability Testing of a Binocular OCT System - EASE StudyExhibit/ Poster Hall
11:4512:00Gus GazzardSurgery, Laser Therapy, Wound Healing5574: LiGHT: Laser in Glaucoma and Ocular Hypertension Trial – Methodology and Baseline characteristics of a multicentre randomised controlled trialBallroom 3